DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLINICAL TRIAL
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 192 participants.
Also called NCT07275515
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 192 participants
- Sponsor
- Registry
-
NCT07275515 -
2025-522687-33-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT07275515. Randomized; quadruple masking; primary purpose treatment. Start 2026-05-19 (actual); primary completion 2029-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLINICAL TRIAL
- Acronym
- DARLENE
- Condition
- Stroke
- Intervention (Drug)
- DRF
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Hospital, Lille
- Collaborator
- Ministère de la Santé
Record details
- Record id
cardio:ct-nct07275515- Content hash
318592d580a8195feb210e6541c1fb738cb0d7714ed0fba92bb6b85e219d5690